DANIEL CHRUSCICKI, M.D.
Ophthalmology Physician · LINCOLN, NE
Individual Active NPI 1861666463
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,750 | 52,021 | $7,120,985 | $4,111,689 | $3,196,692 |
| 2023 | 1,719 | 48,700 | $6,582,513 | $3,980,244 | $3,093,757 |
| 2022 | 1,797 | 21,271 | $7,845,236 | $4,834,990 | $3,771,175 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 36,720 | $35 | $28 |
| 92134 | Imaging of retina | 3,396 | $37 | $26 |
| 92014 | Established patient complete exam of visual system | 2,493 | $116 | $81 |
| 67028 | Injection of drug into eye | 2,363 | $104 | $77 |
| J0178 | Injection, aflibercept, 1 mg | 1,440 | $828 | $657 |
| J0177 | Injection, aflibercept hd, 1 mg | 1,431 | $330 | $263 |
| J3590 | Unclassified biologics | 768 | $89 | $67 |
| 92250 | Photography of the retina | 764 | $31 | $23 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 719 | $147 | $113 |
| J2778 | Injection, ranibizumab, 0.1 mg | 345 | $152 | $120 |
| 92004 | New patient complete exam of visual system | 294 | $138 | $91 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 124 | $82 | $55 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 24568 | NE |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | 24568 | NE |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Nebraska
- NPI 1144217092
- NPI 1104905538
- NPI 1023002847
- NPI 1417952995
- NPI 1023016656
- NPI 1972797769
- NPI 1033107065
- NPI 1932898293
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.